Related Experiment Videos
Intramuscular diazepam in labour. A double-blind trial in multiparae
British Journal of Anaesthesia
|June 1, 1977
Summary
Intramuscular diazepam improved pain relief during labor without increasing pethidine needs. The 0.3 mg/kg dose showed no adverse effects on newborns, offering a potentially beneficial option for labor pain management.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Pain Management
Background:
- Labor pain management is crucial for maternal well-being.
- Existing analgesics may have limitations or side effects.
Purpose of the Study:
- To evaluate the efficacy of intramuscular diazepam for pain relief during labor.
- To assess the impact of diazepam on the need for pethidine.
- To determine the safety of diazepam for neonates.
Main Methods:
- A double-blind study involving 28 multiparous patients.
- Administration of diazepam (0.2 mg/kg or 0.3 mg/kg) or placebo via intramuscular injection.
- Monitoring of pethidine requirements and pain relief quality during labor.
Main Results:
- Diazepam administration did not significantly alter the need for intramuscular pethidine.
- Patients receiving diazepam reported a superior quality of pain relief compared to placebo.
- The 0.3 mg/kg intramuscular diazepam dose exhibited no apparent adverse effects on the neonate.
Conclusions:
- Intramuscular diazepam can enhance pain relief during labor.
- The 0.3 mg/kg dose appears safe for neonates, with no significant impact observed.
- Diazepam presents a promising adjunct for managing labor pain.